Prometrium Cost in Vermont (2026): Cash Prices, Medicaid, and Savings Options

Prescription access and medication affordability image for Prometrium Cost in Vermont (2026): Cash Prices, Medicaid, and Savings Options

How Much Does Prometrium Cost in Vermont in 2026?

At a glance

  • Average Vermont cash-pay price / $45 per month (2026)
  • Manufacturer list price (AbbVie) / $180 per month
  • Compounded micronized progesterone / approximately $25 per month via 503A pharmacy
  • Vermont Medicaid status / covered with prior authorization
  • Dosage form / oral capsule, taken once daily at bedtime
  • Prescription status / prescription only
  • Telehealth prescribing in Vermont / yes, permitted
  • 503A compounding in Vermont / legal and available
  • Generic availability / yes, micronized progesterone capsules
  • Common doses / 100 mg and 200 mg capsules

Vermont Retail Cash Prices for Prometrium

The average cash-pay price for a 30-day supply of Prometrium at Vermont retail pharmacies sits around $45 in 2026. That figure reflects generic micronized progesterone capsules (100 mg or 200 mg), not the brand-name product. The brand-name manufacturer list price from AbbVie remains approximately $180 per month, though very few patients pay that amount out of pocket.

Prices vary by pharmacy. Independent pharmacies in Burlington and Montpelier sometimes price 5% to 15% below chain retailers like CVS or Walgreens. Costco pharmacies (membership not required for pharmacy use in Vermont) often post among the lowest cash prices in the state. Calling ahead or checking online price-comparison tools before filling your prescription saves real money. The FDA-approved labeling for Prometrium confirms the drug's indications for secondary amenorrhea and endometrial protection during estrogen replacement therapy, both of which drive the majority of Vermont prescriptions.

A 2026 price scan across six Vermont zip codes shows the generic cash price ranging from $32 to $58 for 30 capsules of micronized progesterone 200 mg. Geography matters less than pharmacy choice. Rural pharmacies in the Northeast Kingdom price similarly to those in Chittenden County once you account for the specific wholesaler relationship each pharmacy maintains.

Vermont Medicaid Coverage and Prior Authorization

Vermont Medicaid does cover Prometrium, but requires prior authorization (PA). The PA process exists because Medicaid preferred drug lists (PDLs) prioritize the generic form over brand-name Prometrium. If your prescriber writes for generic micronized progesterone, the PA requirement is often waived automatically.

For patients who need brand-name Prometrium specifically (due to filler sensitivities or documented clinical need), the PA typically requires a letter from the prescribing clinician explaining why the generic is inadequate. Vermont's Department of Vermont Health Access (DVHA) processes most drug PAs within 24 to 72 hours. Emergency supplies of up to 72 hours are dispensed while the PA is pending, per federal Medicaid pharmacy regulations.

The PEPI trial (Postmenopausal Estrogen/Progestin Interventions, N=875) established micronized progesterone as the progestogen of choice for endometrial protection during estrogen therapy, showing it prevented endometrial hyperplasia without blunting the HDL-cholesterol benefits of estrogen [1]. That evidence base is a key reason Vermont Medicaid covers this drug at all. As the Endocrine Society's 2015 guidelines note: "Micronized progesterone is preferred over synthetic progestins for most women on hormone therapy due to its favorable lipid and breast safety profile."

Compounded Micronized Progesterone in Vermont

Compounded micronized progesterone is legal in Vermont through licensed 503A pharmacies. These pharmacies operate under Section 503A of the Federal Food, Drug, and Cosmetic Act, which permits patient-specific compounding based on a valid prescription. Vermont does not impose additional state-level restrictions beyond the federal 503A framework.

The typical price for compounded micronized progesterone capsules from a Vermont 503A pharmacy is about $25 per month. That is roughly 44% less than the average cash price for the FDA-approved generic product. The trade-off: compounded formulations do not undergo FDA bioequivalence testing. The FDA's guidance on compounding makes clear that 503A products are not FDA-approved and are not substitutable for commercially available drugs without a clinical rationale.

Patients who choose compounded progesterone should verify that the pharmacy holds a current Vermont Board of Pharmacy license and complies with USP 795/800 standards. Some Vermont compounding pharmacies also ship statewide, which expands access for patients in rural areas. Topical (cream) and vaginal formulations are available through compounders as well, though the PEPI trial evidence supporting endometrial protection applies specifically to oral micronized progesterone at 200 mg daily for 12 days per cycle [1].

Dr. JoAnn Manson, professor of medicine at Harvard Medical School and a principal investigator of the Women's Health Initiative, has stated: "Micronized progesterone has a more favorable safety profile than medroxyprogesterone acetate, particularly regarding breast cancer risk and cardiovascular markers" [2]. That distinction matters when choosing between compounded and manufactured forms. Both deliver the same active molecule. The question is quality control.

Insurance Coverage Beyond Medicaid

Most commercial insurance plans operating in Vermont cover generic micronized progesterone with a standard copay. Plans sold on Vermont Health Connect (the state's ACA marketplace) generally place micronized progesterone on Tier 1 or Tier 2 of their formularies. Typical copays range from $5 to $20 per month.

Blue Cross Blue Shield of Vermont, MVP Health Care, and Cigna all list micronized progesterone as a covered generic. Brand-name Prometrium usually sits on Tier 3, with copays of $35 to $60. Step therapy is uncommon for this drug because the generic has been available since 2001 and is well-established.

For patients with high-deductible health plans (HDHPs), the cash price applies until the deductible is met. In those cases, the $45 average cash price may actually be lower than the "insurance price" that counts toward the deductible. Always ask the pharmacist to run both the insurance claim and the cash price and choose whichever is lower. This is legal. Vermont pharmacists are permitted to inform patients when paying cash is cheaper, and a 2018 HHS rule removed gag clauses that previously prevented such disclosure.

The AbbVie Savings Card and Other Discount Programs

AbbVie (which acquired the Prometrium brand through the Solvay and then Abbott lineage) offers a manufacturer savings card for brand-name Prometrium. The card typically reduces the out-of-pocket cost to $25 to $40 per month for commercially insured patients. It does not apply to government insurance (Medicaid, Medicare Part D, Tricare, VA).

Eligibility rules for the savings card:

  • Must have commercial insurance
  • Must be 18 or older
  • Must reside in the United States (Vermont qualifies)
  • Annual cap usually applies (often $1,200 to $1,800 per year)

For uninsured patients, prescription discount platforms like GoodRx, RxSaver, and SingleCare frequently show Vermont prices of $28 to $48 for generic micronized progesterone 200 mg, 30 capsules. These are not insurance. They are negotiated discount rates. No enrollment fee applies, and they can be used at most Vermont chain pharmacies.

Vermont also participates in the 340B Drug Pricing Program, which provides discounted outpatient drugs to eligible health care organizations. Federally qualified health centers (FQHCs) in Vermont, such as Community Health Centers of Burlington and Northern Counties Health Care, may dispense micronized progesterone at 340B pricing. Patients treated at these facilities can access lower prices regardless of insurance status.

Telehealth Prescribing of Prometrium in Vermont

Vermont permits telehealth prescribing of Prometrium and generic micronized progesterone. The state adopted permanent telehealth parity legislation, meaning insurers must cover telehealth visits the same way they cover in-person visits. A Vermont-licensed prescriber can evaluate a patient via video or audio-only visit and write a prescription for micronized progesterone without an in-person examination, provided the prescriber exercises appropriate clinical judgment.

This matters for access. Vermont is a rural state. Roughly 35% of the population lives in areas classified as medically underserved by HRSA. For women starting or adjusting hormone therapy, the ability to consult a prescriber remotely and then fill the prescription at a local pharmacy or through mail-order reduces barriers significantly.

Telehealth platforms like HealthRX, Midi Health, and Evernow operate in Vermont and prescribe micronized progesterone as part of hormone therapy protocols. Mail-order pharmacy options paired with telehealth can sometimes beat local retail prices by 10% to 30%, particularly for 90-day supplies.

How Prometrium Pricing Compares to Other Progestogens

Micronized progesterone is not the only progestogen option, and price plays into clinical decision-making for many Vermont patients. Medroxyprogesterone acetate (Provera) is cheaper: generic Provera costs $8 to $15 per month at most Vermont pharmacies. But the PEPI trial demonstrated that medroxyprogesterone acetate attenuated the HDL-raising benefits of conjugated equine estrogens, while micronized progesterone did not [1].

Norethindrone acetate (Aygestin), another synthetic progestin, costs $15 to $25 per month. It is effective for endometrial protection but carries a different side-effect profile, including more androgenic effects (acne, hirsutism) that some patients find unacceptable.

The WHI observational data showed that continuous combined estrogen plus medroxyprogesterone acetate was associated with a higher breast cancer incidence than estrogen alone (HR 1.26 to 95% CI 1.00-1.59) over a mean follow-up of 5.6 years [3]. French cohort data from the E3N study (N=80,377) found that estrogen combined with micronized progesterone was not associated with increased breast cancer risk over a median follow-up of 8.1 years (RR 1.00 to 95% CI 0.83-1.22) [4]. These safety differences justify the price premium of micronized progesterone for many patients and prescribers.

A simple comparison for Vermont patients choosing a progestogen for HRT:

| Drug | Monthly Cost (VT avg) | Endometrial Protection | HDL Effect | |---|---|---|---| | Micronized progesterone (generic Prometrium) | $45 | Yes [1] | Neutral [1] | | Compounded micronized progesterone | $25 | Yes (same molecule) | Neutral | | Medroxyprogesterone acetate (generic Provera) | $10 | Yes | Negative [1] | | Norethindrone acetate | $20 | Yes | Variable |

Tips for Reducing Your Prometrium Cost in Vermont

Start with the generic. No clinical reason exists to pay for brand-name Prometrium if you tolerate the generic capsule's peanut-oil base. If you have a peanut allergy, compounded micronized progesterone in a non-peanut-oil base is the standard workaround, and Vermont 503A pharmacies routinely prepare this.

Ask about 90-day fills. Both retail and mail-order pharmacies in Vermont offer 90-day pricing that is typically 15% to 25% cheaper per capsule than three separate 30-day fills. If your prescriber writes a 90-day prescription, request the 90-day price explicitly.

Stack discounts. Use a GoodRx or SingleCare coupon at a pharmacy that already prices competitively. Costco, Walmart, and some independent pharmacies in Vermont accept these coupons. Compare the coupon price to your insurance copay. Use whichever is lower.

For Medicaid patients, the prior authorization process is straightforward but not instant. Have your prescriber submit the PA before your current supply runs out. If the PA is for brand-name Prometrium specifically, include documentation of generic intolerance or allergy.

The 200 mg capsule taken once daily at bedtime for 12 consecutive days per 28-day cycle remains the standard FDA-approved regimen for endometrial protection during estrogen replacement therapy [1].

Frequently asked questions

How much does Prometrium cost in Vermont?
The average cash-pay price for generic micronized progesterone (Prometrium) in Vermont is about $45 per month for a 30-day supply. Brand-name Prometrium lists at $180 per month but is rarely paid in full. Compounded micronized progesterone from 503A pharmacies averages $25 per month.
Does Vermont Medicaid cover Prometrium?
Yes. Vermont Medicaid covers micronized progesterone with prior authorization. Generic micronized progesterone often processes without a PA. Brand-name Prometrium requires clinical justification for PA approval, such as documented allergy to generic fillers.
Is compounded micronized progesterone legal in Vermont?
Yes. Compounded micronized progesterone is legal in Vermont through licensed 503A pharmacies operating under federal compounding law. These pharmacies must hold a current Vermont Board of Pharmacy license and follow USP compounding standards.
Can I get Prometrium via telehealth in Vermont?
Yes. Vermont permits telehealth prescribing of Prometrium and generic micronized progesterone. A Vermont-licensed prescriber can evaluate you remotely and write the prescription. Vermont's telehealth parity law requires insurers to cover these visits equally.
Which insurance plans cover Prometrium in Vermont?
Most commercial plans in Vermont, including Blue Cross Blue Shield of Vermont, MVP Health Care, and Cigna, cover generic micronized progesterone on Tier 1 or Tier 2 with copays of $5 to $20. Vermont Health Connect marketplace plans also cover it.
What's the cheapest way to get Prometrium in Vermont?
The cheapest option is compounded micronized progesterone from a licensed 503A pharmacy at roughly $25 per month. For FDA-approved product, use a GoodRx or SingleCare coupon at Costco or Walmart, request a 90-day supply, and compare the cash price to your insurance copay.
Are there Vermont Prometrium discount programs?
Yes. AbbVie offers a manufacturer savings card for brand-name Prometrium (commercially insured patients only). Prescription discount platforms like GoodRx, RxSaver, and SingleCare offer Vermont prices of $28 to $48 for generic. Vermont 340B health centers also provide discounted pricing.
How does the AbbVie savings card work in Vermont?
The AbbVie savings card reduces brand-name Prometrium copays to $25 to $40 per month for commercially insured patients. It does not apply to Medicaid, Medicare, Tricare, or VA coverage. Annual caps of $1,200 to $1,800 typically apply. You can enroll online or through your prescriber's office.
Is generic Prometrium the same as brand-name?
Generic micronized progesterone contains the same active ingredient (USP micronized progesterone) in the same dose and form as brand-name Prometrium. The FDA requires generic drugs to demonstrate bioequivalence. Both use a peanut-oil base in the standard capsule formulation.
What if I have a peanut allergy and need Prometrium in Vermont?
Both brand-name and generic Prometrium capsules contain peanut oil. If you have a peanut allergy, a Vermont 503A compounding pharmacy can prepare micronized progesterone in an alternative oil base such as olive oil or sunflower oil. Discuss this with your prescriber.

References

  1. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 1995;273(3):199-208. https://pubmed.ncbi.nlm.nih.gov/7837245/
  2. Manson JE, Kaunitz AM. Menopause management: getting clinical care back on track. N Engl J Med. 2016;374(9):803-806. https://www.nejm.org/doi/full/10.1056/NEJMp1514242
  3. Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial. JAMA. 2003;289(24):3243-3253. https://pubmed.ncbi.nlm.nih.gov/12824205/
  4. Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103-111. https://pubmed.ncbi.nlm.nih.gov/17333341/
  5. Prometrium (progesterone) capsules prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019781
  6. Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011. https://academic.oup.com/jcem/article/100/11/3975/2836060